1-5 of 5
Paul C. Tumeh
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

MAPK Signaling and Inflammation Link Melanoma Phenotype Switching to Induction of CD73 during Immunotherapy

Julia Reinhardt, Jennifer Landsberg, Jonathan L. Schmid-Burgk, Bartomeu Bibiloni Ramis, Tobias Bald, Nicole Glodde, Dorys Lopez-Ramos, Arabella Young, Shin Foong Ngiow, Daniel Nettersheim, Hubert Schorle, Thomas Quast, Waldemar Kolanus, Dirk Schadendorf, Georgina V. Long, Jason Madore, Richard A. Scolyer, Antoni Ribas, Mark J. Smyth, Paul C. Tumeh, Thomas Tüting, Michael Hölzel
Journal: Cancer Research
Cancer Res (2017) 77 (17): 4697–4709.
https://doi.org/10.1158/0008-5472.CAN-17-0395
Published: 31 August 2017
View articletitled, MAPK Signaling and Inflammation Link Melanoma Phenotype Switching to Induction of CD73 during Immunotherapy
Open the PDF for MAPK Signaling and Inflammation Link Melanoma Phenotype Switching to Induction of CD73 during Immunotherapy in another window
Includes: Supplementary data
Journal Articles

Abstract NG04: Mechanisms of resistance to anti-PD-1 immunotherapy through interferon pathway mutations

Jesse Zaretsky, Angel Garcia-Diaz, Daniel S. Shin, Helena Escuin-Ordinas, Willy Hugo, Siwen Hu-Lieskovan, Zeynep Eroglu, Davis Y. Torrejon, Paul C. Tumeh, Roger S. Lo, Antoni Ribas
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): NG04.
https://doi.org/10.1158/1538-7445.AM2017-NG04
Published: 01 July 2017
View articletitled, Abstract NG04: Mechanisms of resistance to anti-PD-1 immunotherapy through interferon pathway mutations
Journal Articles

Abstract 5015: TCR usage analysis in blood reveals different mechanisms of action of CTLA-4 and PD-1 blockade in patients

Lidia Robert, Christina L. Harview, Ryan Emerson, Stephen Mok, Blanca Homet, Begonya Comin-Anduix, Richard C. Koya, Harlan Robins, Paul C. Tumeh, Antoni Ribas
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 5015.
https://doi.org/10.1158/1538-7445.AM2014-5015
Published: 01 October 2014
View articletitled, Abstract 5015: TCR usage analysis in blood reveals different mechanisms of action of CTLA-4 and PD-1 blockade in patients
Journal Articles

BRAF Inhibitor Vemurafenib Improves the Antitumor Activity of Adoptive Cell Immunotherapy

Richard C. Koya, Stephen Mok, Nicholas Otte, Kevin J. Blacketor, Begonya Comin-Anduix, Paul C. Tumeh, Aspram Minasyan, Nicholas A. Graham, Thomas G. Graeber, Thinle Chodon, Antoni Ribas
Journal: Cancer Research
Cancer Res (2012) 72 (16): 3928–3937.
https://doi.org/10.1158/0008-5472.CAN-11-2837
Published: 14 August 2012
View articletitled, BRAF Inhibitor Vemurafenib Improves the Antitumor Activity of Adoptive Cell Immunotherapy
Open the PDF for BRAF Inhibitor Vemurafenib Improves the Antitumor Activity of Adoptive Cell Immunotherapy in another window
Includes: Supplementary data
Journal Articles

Abstract 3510: Paradoxical MAPK activation and beneficial effects of vemurafenib on T-cell phenotype resulting in improved functionality in vivo

Richard C. Koya, Stephen Mok, Nicholas Otte, Thinle Chodon, Begonya Comin-Anduix, Kevin Blacketor, Paul C. Tumeh, Antoni Ribas
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 3510.
https://doi.org/10.1158/1538-7445.AM2012-3510
Published: 15 April 2012
View articletitled, Abstract 3510: Paradoxical MAPK activation and beneficial effects of vemurafenib on T-cell phenotype resulting in improved functionality in vivo